▲ BUY
7
/ 10
Conviction
$ Value
$14K
Shares
3,000
Price
$5
Filed
Dec 17
▶ Why this score? (7/10)
- ✓ Open market buy (+3)
- ✓ Director (+1)
- ✓ Cluster: 3 insiders buying (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Germano Geno J
Title
—
CIK
0001424383
Roles
Director
Transaction Details
Transaction Date
2025-12-16
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
23,883
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.718 to $4.720. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
Filing Info
Germano Geno J's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-09 | ENTX | ▲ | $26K |
| 2026-02-10 | ENTX | ▲ | $30K ★ |
| 2025-12-16 | DTIL | ▲ | $14K |
| 2025-07-31 | SAGE | D | — |
| 2025-06-11 | SAGE | A | $0 |
| 2025-06-03 | DTIL | A | $0 |
| 2025-05-27 | DTIL | M | — |
| 2025-05-27 | DTIL | M | $0 |
Other Insiders at DTIL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Kelly John Alexander
Chief Financial Officer
|
— | $31K | 2026-02-18 |
|
SMITH J. JEFFERSON
Chief Research Officer
|
— | $19K | 2026-02-18 |
|
Scimeca Dario
General Counsel and Secretary
|
— | $19K | 2026-02-18 |
|
Amoroso Michael
President and CEO
|
— | $79K | 2026-02-18 |